Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MDM4 | O15151 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26160451 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29446045 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29356265 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29401309 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL119043 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29349978 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL178736 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29508222 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29446029 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL119044 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618852-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2026-05-05 | — | — | US | disclosed |
| US-20260049992-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN INC (US) | 2026-02-19 | — | — | US | disclosed |
| US-20250369980-A1 | MULTIOMIC MASS SPECTROMETRIC IMAGING OF TISSUES USING PHOTOCLEAVABLE MASS-TAG PROBES | AMBEGEN INC (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250067751-A1 | PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN INC (US) | 2025-02-27 | — | — | US | disclosed |
| US-12235277-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2025-02-25 | — | — | US | disclosed |
| US-12181481-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-12181482-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-20240319205-A1 | Novel Photocleavable Mass-Tags for Multiplexed Mass Spectrometric Imaging of Tissues Using Biomolecular Probes | AMBERGEN, INC | 2024-09-26 | — | — | US | disclosed |
| US-12078639-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2024-09-03 | — | — | US | disclosed |
| US-20240264167-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN, INC. | 2024-08-08 | — | — | US | disclosed |
| US-20240077494-A1 | Novel Photocleavable Mass-Tags for Multiplexed Mass Spectrometric Imaging of Tissues Using Biomolecular Probes | AMBERGEN, INC. | 2024-03-07 | — | — | US | disclosed |
| US-11906527-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| US-20230349917-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN, INC. | 2023-11-02 | — | — | US | disclosed |
| US-11789027-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | AMBERGEN, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20220365097-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN, INC. | 2022-11-17 | — | — | US | disclosed |
| US-20220365098-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN, INC | 2022-11-17 | — | — | US | disclosed |
| US-20220137066-A1 | PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-05 | — | — | US | disclosed |
| US-20220137064-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-05 | — | — | US | disclosed |
| US-20220137065-A1 | PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-05 | — | — | US | disclosed |
| US-20220135518-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220365098-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, MSH2 | CASP3 2817/4885KMT2A 1336/4885MDM4 709/4885 |
| US-12235277-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, MKI67, CD68 | CASP3 2526/4885KMT2A 956/4885MDM4 754/4885 |
| US-20230349917-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, MSH2 | CASP3 2817/4885KMT2A 1336/4885MDM4 709/4885 |
| US-20260049992-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | MKI67, CD44, MUC1 | CASP3 1417/4885KMT2A 1222/4885MDM4 700/4885 |
| US-12618852-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, CD68, EPCAM | CASP3 2522/4885KMT2A 2197/4885MDM4 921/4885 |
| US-20240264167-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, MSH2 | CASP3 2817/4885KMT2A 1336/4885MDM4 709/4885 |
| US-11906527-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, MKI67, CD68 | CASP3 2526/4885KMT2A 956/4885MDM4 754/4885 |
| US-12181481-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, MKI67, CD68 | CASP3 2526/4885KMT2A 956/4885MDM4 754/4885 |
| US-20220365097-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, MSH2 | CASP3 2817/4885KMT2A 1336/4885MDM4 709/4885 |
| US-20240319205-A1 | Novel Photocleavable Mass-Tags for Multiplexed Mass Spectrometric Imaging of Tissues Using Biomolecular Probes | CD44, MKI67, MSH2 | CASP3 2817/4885KMT2A 1336/4885MDM4 709/4885 |
| US-11789027-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | MKI67, MSH2, MSH6 | CASP3 1752/4885KMT2A 389/4885MDM4 114/4885 |
| US-20220135518-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, MSH2 | CASP3 2817/4885KMT2A 1336/4885MDM4 709/4885 |
| US-20250067751-A1 | PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | CD44, MKI67, CD68 | CASP3 2526/4885KMT2A 956/4885MDM4 754/4885 |
| US-20240077494-A1 | Novel Photocleavable Mass-Tags for Multiplexed Mass Spectrometric Imaging of Tissues Using Biomolecular Probes | CD44, MKI67, MSH2 | CASP3 2817/4885KMT2A 1336/4885MDM4 709/4885 |
| US-12181482-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | MKI67, MSH2, MSH6 | CASP3 1752/4885KMT2A 389/4885MDM4 114/4885 |
| US-12078639-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, MKI67, CD68 | CASP3 2526/4885KMT2A 956/4885MDM4 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.